Ligand validation:1RR6

IMH: 1,4-DIDEOXY-4-AZA-1-(S)-(9-DEAZAHYPOXANTHIN-9-YL)-D-RIBITOL

IMH is a Ligand Of Interest in 1RR6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1RR6_IMH_A_300	33%	18%	0.197	0.874	2.01	1.52	6	2	0	0	100%	1
2OC4_IMH_A_300	76%	12%	0.12	0.955	1.79	2.29	3	6	1	0	100%	1
2OC9_IMH_A_300	64%	21%	0.128	0.927	1.88	1.46	2	2	2	0	100%	1
2Q7O_IMH_E_291	36%	5%	0.223	0.915	2.42	2.79	6	8	0	4	100%	1
1PF7_IMH_E_290	34%	6%	0.23	0.916	2.91	2.27	9	5	1	0	100%	1
1RT9_IMH_A_300	16%	17%	0.251	0.818	2.06	1.56	6	3	0	0	100%	1
8SWT_IMH_A_300	95%	3%	0.074	0.98	4.92	1.19	9	2	0	0	100%	1
1NW4_IMH_F_306	91%	17%	0.084	0.971	2.21	1.42	6	2	0	0	100%	1
6ZK5_IMH_B_401	91%	22%	0.073	0.959	1.44	1.78	3	3	0	0	100%	1
3MB8_IMH_B_280	83%	15%	0.101	0.959	1.76	1.97	2	4	0	0	100%	1
3FOW_IMH_A_278	80%	14%	0.127	0.977	2.29	1.62	5	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.